These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Excessive cyclosporine trough level variation with classic cyclosporine can be reduced with the new oral microemulsion formulation of cyclosporine. Bökenkamp A, Offner G, Hoyer PF, Wonigeit K, Brodehl J. Transplant Proc; 1996 Aug; 28(4):2273-5. PubMed ID: 8769223 [No Abstract] [Full Text] [Related]
5. Evaluation of tolerability, safety, and efficacy of cyclosporine microemulsion in renal transplant recipients. Gracida C, Melchor JL, Miranda ME, Bartolano C. Transplant Proc; 1996 Aug; 28(4):2171-3. PubMed ID: 8769191 [No Abstract] [Full Text] [Related]
6. Clinical safety and tolerability of microemulsion cyclosporine in stable renal transplant patients. Gracida C, Melchor JL. Transplant Proc; 1996 Dec; 28(6):3379. PubMed ID: 8962318 [No Abstract] [Full Text] [Related]
7. Conversion from Sandimmune to Neoral and induction therapy with Neoral in pediatric renal transplant recipients. Hoyer PF, Boekenkamp A, Vester U, Offner G, Brodehl J. Transplant Proc; 1996 Aug; 28(4):2259-61. PubMed ID: 8769218 [No Abstract] [Full Text] [Related]
12. Conversion from Sandimmune to Neoral in stable renal transplant recipients. Sandoz Study Group OLN-353. Pescovitz MD. Transplant Proc; 1996 Aug; 28(4):2196-8. PubMed ID: 8769198 [No Abstract] [Full Text] [Related]
13. Experience with clinical use of Sandimmun Neoral in renal transplant patients. Min ZL, Zhao M, Zhu YH, Qi J, Wang LM, Wang YW. Transplant Proc; 1996 Jun; 28(3):1356-7. PubMed ID: 8658692 [No Abstract] [Full Text] [Related]
15. Cyclosporine pharmacokinetic profiles in stable renal allograft recipients converting from Sandimmun to Neoral. Vathsala A, Lee WT, Jacob E, Woo KT. Transplant Proc; 1996 Jun; 28(3):1324-6. PubMed ID: 8658678 [No Abstract] [Full Text] [Related]
16. Safety and effectiveness of microemulsion cyclosporine in renal allograft recipients: 1-year follow-up study. Park K, Kim MS, Kim SI, Kim YS, Moon JI. Transplant Proc; 1998 Nov; 30(7):3556-7. PubMed ID: 9838557 [No Abstract] [Full Text] [Related]
17. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results. Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M, European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group. Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208 [Abstract] [Full Text] [Related]
18. Clinical experience in transferring kidney transplant patients from sandimmun to sandimmun neoral--results after 6 months. Neumayer HH, Färber L, Haller P, Kohnen R, Maibücher A, Schuster A, Vollmar J, Waiser J. Transplant Proc; 1995 Oct; 27(5):2679-82. PubMed ID: 7482873 [No Abstract] [Full Text] [Related]
19. Conversion from Sandimmune to Neoral in stable liver graft recipients. Pollard SG, Lodge JP. Transplant Proc; 1996 Aug; 28(4):2244-6. PubMed ID: 8769213 [No Abstract] [Full Text] [Related]